首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Atomic structure of the autosomal recessive hypercholesterolemia phosphotyrosine-binding domain in complex with the LDL-receptor tail
【2h】

Atomic structure of the autosomal recessive hypercholesterolemia phosphotyrosine-binding domain in complex with the LDL-receptor tail

机译:常染色体隐性高胆固醇血症磷酸酪氨酸结合结构域与LDL受体尾部复合的原子结构

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hypercholesterolemia, high serum cholesterol in the form of LDL, is a major risk factor for atherosclerosis. LDL is mostly degraded in the liver after its cellular internalization with the LDL receptor (LDLR). This clathrin-mediated endocytosis depends on the protein autosomal recessive hypercholesterolemia (ARH), which binds the LDLR cytoplasmic tail. Mutations in either the LDLR tail or in ARH lead to hypercholesterolemia and premature atherosclerosis. Despite the significance of this interaction for cholesterol homeostasis, no structure of either ARH or the LDLR tail is available to determine its molecular basis. We report the crystal structure at 1.37-Å resolution of the phosphotyrosine-binding (PTB) domain of ARH in complex with an LDLR tail peptide containing the FxNPxY0 internalization signal. Surprisingly, ARH interacts with a longer portion of the tail than previously recognized, which extends to I-7xF-5xNPxY0QK+2. The LDLR tail assumes a unique “Hook”-like structure with a double β-turn conformation, which is accommodated in distinctive ARH structural determinants (i.e., an extended backbone hydrogen-bonding platform, three hydrophobic helical grooves, and a hydrophobic pocket for Y0). This unique complementarity differs significantly in related PTB proteins and may account for the unique physiological role of these partners in the hepatic uptake of cholesterol LDL. Moreover, the unusual hydrophobic pocket for Y0 explains the distinctive ability of ARH to internalize proteins containing either FxNPxY0 or FxNPxF0 sequences. Biophysical measurements reveal how mutations associated with hypercholesterolemia destabilize ARH and its complex with LDLR and illuminate LDL internalization defects seen in patients.
机译:高胆固醇血症(LDL形式的高血清胆固醇)是动脉粥样硬化的主要危险因素。 LDL在细胞内被LDL受体(LDLR)内化后,大部分在肝脏中降解。网格蛋白介导的内吞作用取决于常染色体隐性隐性高胆固醇血症(ARH),该蛋白结合LDLR胞质尾巴。 LDLR尾部或ARH中的突变会导致高胆固醇血症和过早的动脉粥样硬化。尽管这种相互作用对于胆固醇稳态具有重要意义,但目前尚无ARH或LDLR尾部的结构来确定其分子基础。我们报告晶体结构在与含有FxNPxY0内部化信号的LDLR尾肽复杂的ARH的磷酸酪氨酸结合(PTB)域的1.37-Å分辨率。出乎意料的是,ARH与尾巴的相互作用比以前认识到的更长,延伸至I-7xF-5xNPxY0QK + 2。 LDLR尾部假定具有独特的“钩”状结构,具有双β-转角构象,可容纳在独特的ARH结构决定簇中(即,扩展的主链氢键平台,三个疏水性螺旋凹槽和一个用于Y0的疏水性囊袋) )。这种独特的互补性在相关的PTB蛋白中有显着差异,并且可以解释这些伴侣在肝脏摄取胆固醇LDL中的独特生理作用。此外,Y0的不寻常的疏水性口袋解释了ARH内在化包含FxNPxY0或FxNPxF0序列的蛋白质的独特能力。生物物理测量结果显示,与高胆固醇血症相关的突变如何使ARH及其与LDLR的复合物不稳定并阐明患者中发现的LDL内部化缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号